| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8507785 | Acta Pharmaceutica Sinica B | 2018 | 9 Pages |
Abstract
A liposomal curcumin dry powder inhaler (LCD) was developed for inhalation treatment of primary lung cancer. LCDs are a promising medication for inhalation treatment of lung cancer with high therapeutic efficiency.383
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
Authors
Tongtong Zhang, Yanming Chen, Yuanyuan Ge, Yuzhen Hu, Miao Li, Yiguang Jin,